CA1045975A - Enzyme degradable medicament carriers - Google Patents

Enzyme degradable medicament carriers

Info

Publication number
CA1045975A
CA1045975A CA219,603A CA219603A CA1045975A CA 1045975 A CA1045975 A CA 1045975A CA 219603 A CA219603 A CA 219603A CA 1045975 A CA1045975 A CA 1045975A
Authority
CA
Canada
Prior art keywords
poly
acetyl
glucosamine
drug
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA219,603A
Other languages
English (en)
French (fr)
Inventor
Richard C. Capozza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of CA1045975A publication Critical patent/CA1045975A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA219,603A 1974-02-11 1975-02-07 Enzyme degradable medicament carriers Expired CA1045975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US441695A US3911098A (en) 1974-02-11 1974-02-11 Medicament carrier

Publications (1)

Publication Number Publication Date
CA1045975A true CA1045975A (en) 1979-01-09

Family

ID=23753927

Family Applications (1)

Application Number Title Priority Date Filing Date
CA219,603A Expired CA1045975A (en) 1974-02-11 1975-02-07 Enzyme degradable medicament carriers

Country Status (19)

Country Link
US (1) US3911098A (xx)
JP (1) JPS50123815A (xx)
AR (1) AR206618A1 (xx)
BE (1) BE825367A (xx)
CA (1) CA1045975A (xx)
CS (1) CS207808B1 (xx)
DD (1) DD118801A5 (xx)
DE (1) DE2505305A1 (xx)
ES (1) ES434618A1 (xx)
FR (1) FR2260356B1 (xx)
GB (1) GB1499751A (xx)
IL (1) IL46496A (xx)
IT (1) IT1036866B (xx)
NL (1) NL7501365A (xx)
PH (1) PH13485A (xx)
PL (1) PL177948A1 (xx)
RO (1) RO68711A (xx)
SE (1) SE7501464L (xx)
ZA (1) ZA75472B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4066747A (en) * 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
DE2861226D1 (en) * 1977-06-28 1981-12-10 Univ Strathclyde A pharmaceutical composition for tropical diseases
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
JPS57134412A (en) * 1981-02-12 1982-08-19 Unitika Ltd Biodegradable drug donor
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US5277900A (en) * 1982-08-07 1994-01-11 Henkel Kommanditgesellschaft Auf Aktien Method for blood coagulation on hard tissues
JPS6036410A (ja) * 1983-08-08 1985-02-25 Unitika Ltd 生分解性薬物供与体の製造方法
US5290752A (en) * 1984-03-16 1994-03-01 Unitika Ltd. Method for preparation of a shaped chitin body containing a physiologically active substance
JPH0623091B2 (ja) * 1984-03-16 1994-03-30 ユニチカ株式会社 キチン成形体の製造法
JPS62193638A (ja) * 1986-02-20 1987-08-25 Kao Corp 顆粒剤
US4931551A (en) * 1988-07-05 1990-06-05 University Of Delaware Dispersions of chitin and product therefrom
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
US5741329A (en) * 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US6065476A (en) * 1994-12-21 2000-05-23 Board Of Regents, University Of Texas System Method of enhancing surface porosity of biodegradable implants
US6767899B1 (en) 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US7018646B2 (en) * 2002-05-30 2006-03-28 Van Dalen Johan T W Apparatus and method for delivering controlled quantities of one or more agents to the eye
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7699863B2 (en) * 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DK2858604T3 (da) 2012-06-07 2024-05-21 Epitomee Medical Ltd Ekspanderet anordning
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
EP3091962B1 (en) 2013-12-05 2022-06-08 Epitomee Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2040879A (en) * 1934-06-21 1936-05-19 Du Pont Substantially undegraded deacetylated chitin and process for producing the same
US2040880A (en) * 1934-06-21 1936-05-19 Du Pont Process for the preparation of films and filaments and products thereof
US2168374A (en) * 1936-07-09 1939-08-08 Visking Corp Chemical compounds and products produced therefrom
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method

Also Published As

Publication number Publication date
AR206618A1 (es) 1976-08-06
RO68711A (ro) 1980-10-30
IL46496A (en) 1978-08-31
BE825367A (fr) 1975-08-11
DD118801A5 (xx) 1976-03-20
AU7760275A (en) 1976-07-29
PL177948A1 (en) 1978-04-10
GB1499751A (en) 1978-02-01
FR2260356B1 (xx) 1978-07-28
NL7501365A (nl) 1975-08-13
US3911098A (en) 1975-10-07
DE2505305A1 (de) 1975-08-21
IL46496A0 (en) 1975-06-25
FR2260356A1 (xx) 1975-09-05
ZA75472B (en) 1976-01-28
JPS50123815A (xx) 1975-09-29
CS207808B1 (en) 1981-08-31
PH13485A (en) 1980-05-21
SE7501464L (xx) 1975-08-12
ES434618A1 (es) 1977-04-16
IT1036866B (it) 1979-10-30

Similar Documents

Publication Publication Date Title
CA1045975A (en) Enzyme degradable medicament carriers
AU762677B2 (en) Prolonged release bioadhesive vaginal gel dosage form
US9421246B2 (en) Ingestible formulations for transient, noninvasive reduction of gastric volume
US5888493A (en) Ophthalmic aqueous gel formulation and related methods
FI93608C (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
JP2009509982A (ja) 内耳疾患を治療するための医薬品組成物
JP2001519787A (ja) 膀胱内ドラッグデリバリーシステム
US20050089577A1 (en) Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
WO1994005257A1 (en) Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
WO2001074400A1 (fr) Transporteurs et systeme de distribution de medicament les utilisant
EP0497956B1 (en) Controlled release formulations
JP6595717B2 (ja) 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法
JP2008517043A (ja) 放出プログラム化によるバイオ接着剤組成
CN113842358B (zh) 一种兽用子宫注入剂及其制备方法和应用
CN113908153B (zh) 一种布瓦西坦药物组合物、其制备方法及应用
JPS597684B2 (ja) コラ−ゲンを用いた眼用徐放性制御医薬剤
WO1997029777A1 (fr) Systeme d'administration de medicament utilisant une galactoxyloglucane
JP2671381B2 (ja) 点眼剤
RU2139093C1 (ru) Устройство подачи лекарственного средства и способ изготовления такого устройства
WO1992018101A1 (en) Vaginal drug delivery device
JP2921872B2 (ja) 経粘膜製剤
RU2098079C1 (ru) Глазной гель
Severian Drug-Loaded Ophthalmic Prostheses
CN111954533A (zh) 治疗血液中的耳念珠菌的方法和药物组合物
RU2088215C1 (ru) Глазные капли